English Français
Register Sign In
Search Results

If you make changes to this saved search, you'll find the original and new searches in your account.

Your search filters:

Bempedoic Acid/Ezetimibe Combo

Narrow by:

Organization
Industry
  • Show Top 5

Subject
  • Show All

  • Show Top 5

Tag
  • Show More

  • Show Top 5

Date Published





Language
  • Show Top 5

Country
  • Show Top 5

State/Province
  • Show Top 5

Stock Market
  • Show Top 5

Continent
  • Show Top 5

Showing 1-9 of about 9 articles.

  • 1

Esperion Therapeutics, Inc.

Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference

about 105 days ago 

Esperion Therapeutics, Inc.

Esperion Announces the Appointment of Jeffrey Berkowitz to Board of Directors

about 125 days ago 

Esperion Therapeutics, Inc.

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

about 138 days ago 

Esperion Therapeutics, Inc.

Esperion to Participate in Fireside Chat at the Stifel 2017 Healthcare Conference

about 160 days ago 

Esperion Therapeutics, Inc.

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Third Quarter 2017 Financial Results

about 162 days ago 

Esperion Therapeutics, Inc.

Esperion Announces Initiation of Pivotal Phase 3 Study for the Bempedoic Acid / Ezetimibe Combination Pill

about 163 days ago 

Esperion Therapeutics, Inc.

Esperion to Host Analyst and Investor Day Event on October 17

about 190 days ago 

Esperion Therapeutics, Inc.

Esperion Provides Bempedoic Acid Franchise Development Program Updates; Reports Second Quarter 2017 Financial Results

about 253 days ago 

Esperion Therapeutics, Inc.

Esperion Announces Positive Top-Line Results From Phase 2 Study of Bempedoic Acid / Ezetimibe Combination Plus Atorvastatin

about 254 days ago  photo-release

Showing 1-9 of about 9 articles.

  • 1
Newswire Distribution Network & Management
  • Home
  • Newsroom
  • RSS Feeds
  • Legal
  • Contact Us
About Us
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
© 2018 GlobeNewswire, Inc. All Rights Reserved.